You have access
Studying Navitoclax, a Targeted Anticancer Drug, in Healthy Volunteers – Ethical Considerations and Risk/Benefit Assessments and Management
HAO XIONG, RAJENDRA S. PRADHAN, ADEL NADA, ANDREW P. KRIVOSHIK, KYLE D. HOLEN, JAMES W. RHODES, GARY B. GORDON, ROD HUMERICKHOUSE and WALID M. AWNI
Anticancer Research July 2014, 34 (7) 3739-3746;